Thursday, September 17, 2020

Potential target identified for migraine therapy

Researchers have identified the protein GLT-1 as the neurotransmitter glutamate transporter in the brain that is related to cortical spreading depression, a pathological condition that underlies migraines. The researchers found that mice lacking GLT-1, but not other glutamate receptors, were more susceptible to cortical spreading depression than were controls. GLT-1 might therefore be a potential target for migraine therapy.

from Top Health News -- ScienceDaily https://ift.tt/2EbRR9P

No comments:

Post a Comment

Ebola and hantavirus can start like the flu but turn deadly fast

Two dangerous viruses are back in the spotlight, reminding health officials how quickly infectious diseases can become serious threats. Hant...